The global media landscape reached a fever pitch on February 24, 2026, as the high-stakes battle for the soul of Hollywood entered its most volatile phase yet. Netflix (NASDAQ: NFLX), once the disruptor that refused to play by traditional studio rules, is now locked in a precarious struggle to finalize
The cybersecurity sector faced a seismic shift this week following the unveiling of “Claude Code Security,” a groundbreaking AI-powered code-scanning tool from Anthropic. The release, which promises to automate the discovery and remediation of complex software vulnerabilities through high-level reasoning, has sent shockwaves through Wall Street. Investors, fearing that the
The US stock market staged a definitive recovery on Tuesday, February 24, 2026, as a duo of upbeat economic reports provided the "soft landing" narrative with much-needed oxygen. Following a bruising Monday session that saw major indices retreat on fears of trade volatility and cooling tech demand, the release of
The global financial landscape was thrust into a state of high-octane volatility this week as President Trump announced a transition to a 15% blanket global tariff, effectively circumventing a landmark Supreme Court ruling that had briefly threatened his "America First" trade agenda. The move, characterized by the administration as a
Industrial and commercial distributor Global Industrial (NYSE:GIC) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 14.3% year on year to $345.6 million. Its GAAP profit of $0.38 per share was 18.8% above analysts’ consensus estimates.
Domain registrar and web services company GoDaddy (NYSE:GDDY) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 6.8% year on year to $1.27 billion. On the other hand, next quarter’s revenue guidance of $1.26 billion was less impressive, coming in 1.4% below analysts’ estimates. Its GAAP profit of $1.80 per share was 14% above analysts’ consensus estimates.
Biopharma company Corcept Therapeutics (NASDAQ:CORT) fell short of the market’s revenue expectations in Q4 CY2025, but sales rose 11.1% year on year to $202.1 million. Its GAAP profit of $0.20 per share was 26.3% below analysts’ consensus estimates.
Medical device company Globus Medical (NYSE:GMED) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 25.7% year on year to $826.4 million. The company’s full-year revenue guidance of $3.2 billion at the midpoint came in 1.2% above analysts’ estimates. Its non-GAAP profit of $1.28 per share was 11% above analysts’ consensus estimates.
Composite decking and railing products manufacturer Trex Company (NYSE:TREX) beat Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 3.9% year on year to $161.1 million. The company’s full-year revenue guidance of $1.21 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $0.04 per share was significantly above analysts’ consensus estimates.
Healthcare solutions company Evolent Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 27.5% year on year to $468.7 million. The company’s full-year revenue guidance of $2.5 billion at the midpoint came in 4.9% above analysts’ estimates. Its non-GAAP profit of $0.08 per share was 62.7% above analysts’ consensus estimates.
Medical device company Merit Medical Systems (NASDAQ:MMSI) announced better-than-expected revenue in Q4 CY2025, with sales up 10.9% year on year to $393.9 million. The company’s full-year revenue guidance of $1.62 billion at the midpoint came in 0.9% above analysts’ estimates. Its non-GAAP profit of $0.93 per share was 2.5% below analysts’ consensus estimates.
Traffic solutions company Verra Mobility (NYSE:VRRM) announced better-than-expected revenue in Q4 CY2025, with sales up 16.4% year on year to $257.9 million. The company expects the full year’s revenue to be around $1.03 billion, close to analysts’ estimates. Its non-GAAP profit of $0.30 per share was 4.1% below analysts’ consensus estimates.
Professional services firm Huron Consulting Group (NASDAQ:HURN) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 10.7% year on year to $442 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $1.82 billion at the midpoint. Its non-GAAP profit of $2.17 per share was 11.3% above analysts’ consensus estimates.
MMCAP International increased its stake in NexGen Energy during the fourth quarter, deepening exposure to the company’s Rook I uranium project in Canada. As governments extend reactor lifespans and reconsider nuclear expansion, attention is turning to future uranium supply and how quickly projects like Rook I can begin production.
Infrastructure equipment supplier SPX Technologies (NYSE:SPXC) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 19.4% year on year to $637.3 million. The company’s full-year revenue guidance of $2.57 billion at the midpoint came in 3.8% above analysts’ estimates. Its non-GAAP profit of $1.88 per share was 0.7% above analysts’ consensus estimates.
Real estate technology company eXp World (NASDAQ:EXPI) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 8.5% year on year to $1.19 billion. Its GAAP loss of $0.08 per share was significantly below analysts’ consensus estimates.
Given its solid fundamentals, strong balance sheet, steady cash flow generation, and promising growth outlook, Whitecap Resources appears well-positioned to appeal to income-focused investors seeking both stability and long-term return potential.
Medical products company UFP Technologies (NASDAQ:UFPT) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 3.4% year on year to $148.9 million. Its non-GAAP profit of $2.44 per share was 9.2% above analysts’ consensus estimates.
